BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brown KA, Khanafer N, Daneman N, Fisman DN. Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother 2013;57:2326-32. [PMID: 23478961 DOI: 10.1128/AAC.02176-12] [Cited by in Crossref: 305] [Cited by in F6Publishing: 134] [Article Influence: 33.9] [Reference Citation Analysis]
Number Citing Articles
1 Iacob S, Iacob DG. Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis. Front Microbiol 2019;10:1676. [PMID: 31447793 DOI: 10.3389/fmicb.2019.01676] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
2 Teng AM, Kvizhinadze G, Nair N, McLeod M, Wilson N, Blakely T. A screening program to test and treat for Helicobacter pylori infection: Cost-utility analysis by age, sex and ethnicity. BMC Infect Dis 2017;17:156. [PMID: 28219322 DOI: 10.1186/s12879-017-2259-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
3 Baggs J, Jernigan JA, Halpin AL, Epstein L, Hatfield KM, McDonald LC. Risk of Subsequent Sepsis Within 90 Days After a Hospital Stay by Type of Antibiotic Exposure. Clin Infect Dis 2018;66:1004-12. [PMID: 29136126 DOI: 10.1093/cid/cix947] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 18.3] [Reference Citation Analysis]
4 Lomeli BK, Galbraith H, Schettler J, Saviolakis GA, El-Amin W, Osborn B, Ravel J, Hazleton K, Lozupone CA, Evans RJ, Bell SJ, Ochsner UA, Jarvis TC, Baqar S, Janjic N. Multiple-Ascending-Dose Phase 1 Clinical Study of the Safety, Tolerability, and Pharmacokinetics of CRS3123, a Narrow-Spectrum Agent with Minimal Disruption of Normal Gut Microbiota. Antimicrob Agents Chemother 2019;64:e01395-19. [PMID: 31685472 DOI: 10.1128/AAC.01395-19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
5 Schönherr SG, Ranft D, Lippmann N, Lübbert C. Changes in antibiotic consumption, AMR and Clostridioides difficile infections in a large tertiary-care center following the implementation of institution-specific guidelines for antimicrobial therapy: A nine-year interrupted time series study. PLoS One 2021;16:e0258690. [PMID: 34648594 DOI: 10.1371/journal.pone.0258690] [Reference Citation Analysis]
6 Turner NA, Wrenn R, Sarubbi C, Kleris R, Lugar PL, Radojicic C, Moehring RW, Anderson DJ. Evaluation of a Pharmacist-Led Penicillin Allergy Assessment Program and Allergy Delabeling in a Tertiary Care Hospital. JAMA Netw Open 2021;4:e219820. [PMID: 33983399 DOI: 10.1001/jamanetworkopen.2021.9820] [Reference Citation Analysis]
7 Cappetto CM. Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis. Am J Health Syst Pharm 2021;78:1374-81. [PMID: 33851215 DOI: 10.1093/ajhp/zxab161] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Sanchez GV, Babiker A, Master RN, Luu T, Mathur A, Bordon J. Antibiotic Resistance among Urinary Isolates from Female Outpatients in the United States in 2003 and 2012. Antimicrob Agents Chemother 2016;60:2680-3. [PMID: 26883714 DOI: 10.1128/AAC.02897-15] [Cited by in Crossref: 66] [Cited by in F6Publishing: 31] [Article Influence: 11.0] [Reference Citation Analysis]
9 Li C, Duan J, Liu S, Meng X, Fu C, Zeng C, Wu A. Assessing the risk and disease burden of Clostridium difficile infection among patients with hospital-acquired pneumonia at a University Hospital in Central China. Infection 2017;45:621-8. [PMID: 28497295 DOI: 10.1007/s15010-017-1024-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
10 Seo SK, Gedrimaite Z, Fleischer D, Cohen N, Petre E, Brown KT, Covey A. Impact of Eliminating Postprocedural Antibiotic Prophylaxis in Patients without Biliary Instrumentation or Bypass Undergoing Hepatic Artery Embolization for Hepatic Malignancies. J Vasc Interv Radiol 2019;30:1895-900. [PMID: 31668968 DOI: 10.1016/j.jvir.2019.07.023] [Reference Citation Analysis]
11 Ajami NJ, Cope JL, Wong MC, Petrosino JF, Chesnel L. Impact of Oral Fidaxomicin Administration on the Intestinal Microbiota and Susceptibility to Clostridium difficile Colonization in Mice. Antimicrob Agents Chemother 2018;62:e02112-17. [PMID: 29463537 DOI: 10.1128/AAC.02112-17] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
12 Walsh TL, Bremmer DN, Moffa MA, Chan-Tompkins NH, Murillo MA, Chan L, Burkitt MJ, Konopka CI, Watson C, Trienski TL. Effect of Antimicrobial Stewardship Program Guidance on the Management of Uncomplicated Skin and Soft Tissue Infections in Hospitalized Adults. Mayo Clin Proc Innov Qual Outcomes 2017;1:91-9. [PMID: 30225405 DOI: 10.1016/j.mayocpiqo.2017.04.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ferreira A, Bolland MJ, Thomas MG. Meta-analysis of randomised trials comparing a penicillin or cephalosporin with a macrolide or lincosamide in the treatment of cellulitis or erysipelas. Infection 2016;44:607-15. [PMID: 27085865 DOI: 10.1007/s15010-016-0895-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
14 Gudiol C, Albasanz-Puig A, Laporte-Amargós J, Pallarès N, Mussetti A, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo M, Mikulska M, Martín-Dávila P, Herrera F, Gasch O, Drgona L, Paz Morales H, Brunel AS, García E, Isler B, Kern WV, Morales I, Maestro-de la Calle G, Montero M, Kanj SS, Sipahi OR, Calik S, Márquez-Gómez I, Marin JI, Gomes MZR, Hemmatti P, Araos R, Peghin M, Del Pozo JL, Yáñez L, Tilley R, Manzur A, Novo A, Carratalà J; IRONIC Study Group. Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa. Antimicrob Agents Chemother 2020;64:e02494-19. [PMID: 32015035 DOI: 10.1128/AAC.02494-19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
15 Appaneal HJ, Shireman TI, Lopes VV, Mor V, Dosa DM, LaPlante KL, Caffrey AR. Poor clinical outcomes associated with suboptimal antibiotic treatment among older long-term care facility residents with urinary tract infection: a retrospective cohort study. BMC Geriatr 2021;21:436. [PMID: 34301192 DOI: 10.1186/s12877-021-02378-5] [Reference Citation Analysis]
16 Fu Y, Luo Y, Grinspan AM. Epidemiology of community-acquired and recurrent Clostridioides difficile infection. Therap Adv Gastroenterol 2021;14:17562848211016248. [PMID: 34093740 DOI: 10.1177/17562848211016248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kwak R, Lopez CG, Noe MH, Nambudiri VE, Charrow AP. No increased incidence of Clostridium difficile infection among patients with hidradenitis suppurativa treated with systemic clindamycin. J Am Acad Dermatol 2021:S0190-9622(21)02362-8. [PMID: 34428535 DOI: 10.1016/j.jaad.2021.08.028] [Reference Citation Analysis]
18 Thaulow CM, Blix HS, Eriksen BH, Ask I, Myklebust TÅ, Berild D. Using a period incidence survey to compare antibiotic use in children between a university hospital and a district hospital in a country with low antimicrobial resistance: a prospective observational study. BMJ Open 2019;9:e027836. [PMID: 31138583 DOI: 10.1136/bmjopen-2018-027836] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Dingle KE, Didelot X, Quan TP, Eyre DW, Stoesser N, Golubchik T, Harding RM, Wilson DJ, Griffiths D, Vaughan A, Finney JM, Wyllie DH, Oakley SJ, Fawley WN, Freeman J, Morris K, Martin J, Howard P, Gorbach S, Goldstein EJC, Citron DM, Hopkins S, Hope R, Johnson AP, Wilcox MH, Peto TEA, Walker AS, Crook DW; Modernising Medical Microbiology Informatics Group. Effects of control interventions on Clostridium difficile infection in England: an observational study. Lancet Infect Dis 2017;17:411-21. [PMID: 28130063 DOI: 10.1016/S1473-3099(16)30514-X] [Cited by in Crossref: 196] [Cited by in F6Publishing: 80] [Article Influence: 39.2] [Reference Citation Analysis]
20 Ofosu A. Clostridium difficile infection: a review of current and emerging therapies. Ann Gastroenterol 2016;29:147-54. [PMID: 27065726 DOI: 10.20524/aog.2016.0006] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 10.2] [Reference Citation Analysis]
21 Gandhi AR, Rao SR, Chen LH, Nelson MD, Ryan ET, LaRocque RC, Hyle EP. Prescribing Patterns of Antibiotics for the Self-Treatment of Travelers' Diarrhea in Global TravEpiNet, 2009-2018. Open Forum Infect Dis 2020;7:ofaa376. [PMID: 33072808 DOI: 10.1093/ofid/ofaa376] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Scholl UI, Abriola L, Zhang C, Reimer EN, Plummer M, Kazmierczak BI, Zhang J, Hoyer D, Merkel JS, Wang W, Lifton RP. Macrolides selectively inhibit mutant KCNJ5 potassium channels that cause aldosterone-producing adenoma. J Clin Invest 2017;127:2739-50. [PMID: 28604387 DOI: 10.1172/JCI91733] [Cited by in Crossref: 41] [Cited by in F6Publishing: 14] [Article Influence: 8.2] [Reference Citation Analysis]
23 Carvour ML, Wilder SL, Ryan KL, Walraven C, Qeadan F, Brett M, Page K. Predictors of Clostridium difficile infection and predictive impact of probiotic use in a diverse hospital-wide cohort. Am J Infect Control 2019;47:2-8. [PMID: 30205907 DOI: 10.1016/j.ajic.2018.07.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
24 Ruzante JM, Olin K, Munoz B, Nawrocki J, Selvarangan R, Meyers L. Real-time gastrointestinal infection surveillance through a cloud-based network of clinical laboratories. PLoS One 2021;16:e0250767. [PMID: 33930062 DOI: 10.1371/journal.pone.0250767] [Reference Citation Analysis]
25 Furuya-Kanamori L, McKenzie SJ, Yakob L, Clark J, Paterson DL, Riley TV, Clements AC. Clostridium difficile infection seasonality: patterns across hemispheres and continents - a systematic review. PLoS One 2015;10:e0120730. [PMID: 25775463 DOI: 10.1371/journal.pone.0120730] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
26 AlJindan R, AlEraky DM, Borgio JF, AbdulAzeez S, Abdalhamid B, Mahmoud N, Farhat M. Diagnostic deficiencies of C. difficile infection among patients in a tertiary hospital in Saudi Arabia: A laboratory-based case series. Saudi J Biol Sci 2021;28:4472-7. [PMID: 34354432 DOI: 10.1016/j.sjbs.2021.04.044] [Reference Citation Analysis]
27 Parker KS, Wilson JD, Marschall J, Mucha PJ, Henderson JP. Network Analysis Reveals Sex- and Antibiotic Resistance-Associated Antivirulence Targets in Clinical Uropathogens. ACS Infect Dis 2015;1:523-32. [PMID: 26985454 DOI: 10.1021/acsinfecdis.5b00022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
28 Roncarati G, Dallolio L, Leoni E, Panico M, Zanni A, Farruggia P. Surveillance of Clostridium difficile Infections: Results from a Six-Year Retrospective Study in Nine Hospitals of a North Italian Local Health Authority. Int J Environ Res Public Health 2017;14:E61. [PMID: 28075419 DOI: 10.3390/ijerph14010061] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
29 Brown KA, Fisman DN, Moineddin R, Daneman N. The magnitude and duration of Clostridium difficile infection risk associated with antibiotic therapy: a hospital cohort study. PLoS One 2014;9:e105454. [PMID: 25157757 DOI: 10.1371/journal.pone.0105454] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
30 Berkell M, Mysara M, Xavier BB, van Werkhoven CH, Monsieurs P, Lammens C, Ducher A, Vehreschild MJGT, Goossens H, de Gunzburg J, Bonten MJM, Malhotra-Kumar S; ANTICIPATE study group. Microbiota-based markers predictive of development of Clostridioides difficile infection. Nat Commun 2021;12:2241. [PMID: 33854066 DOI: 10.1038/s41467-021-22302-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Rhee C, Kadri SS, Dekker JP, Danner RL, Chen HC, Fram D, Zhang F, Wang R, Klompas M; CDC Prevention Epicenters Program. Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use. JAMA Netw Open 2020;3:e202899. [PMID: 32297949 DOI: 10.1001/jamanetworkopen.2020.2899] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 19.0] [Reference Citation Analysis]
32 Páramo-Zunzunegui J, Ortega-Fernández I, Calvo-Espino P, Diego-Hernández C, Ariza-Ibarra I, Otazu-Canals L, Danés-Grases JE, Menchero-Sánchez A. Severe Clostridium difficile colitis as potential late complication associated with COVID-19. Ann R Coll Surg Engl 2020;102:e176-9. [PMID: 32803988 DOI: 10.1308/rcsann.2020.0166] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Rolling T, Hohl TM, Zhai B. Minority report: the intestinal mycobiota in systemic infections. Curr Opin Microbiol 2020;56:1-6. [PMID: 32599521 DOI: 10.1016/j.mib.2020.05.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
34 Saint-Lu N, Burdet C, Sablier-Gallis F, Corbel T, Nevière A, Sayah-Jeanne S, Pulse M, Weiss W, Ferreira S, Andremont A, Mentré F, de Gunzburg J. DAV131A Protects Hamsters from Lethal Clostridioides difficile Infection Induced by Fluoroquinolones. Antimicrob Agents Chemother 2019;64:e01196-19. [PMID: 31636067 DOI: 10.1128/AAC.01196-19] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Febvre HP, Rao S, Gindin M, Goodwin NDM, Finer E, Vivanco JS, Lu S, Manter DK, Wallace TC, Weir TL. PHAGE Study: Effects of Supplemental Bacteriophage Intake on Inflammation and Gut Microbiota in Healthy Adults. Nutrients 2019;11:E666. [PMID: 30897686 DOI: 10.3390/nu11030666] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 10.7] [Reference Citation Analysis]
36 Jump RLP, Gaur S, Katz MJ, Crnich CJ, Dumyati G, Ashraf MS, Frentzel E, Schweon SJ, Sloane P, Nace D; Infection Advisory Committee for AMDA—The Society of Post-Acute and Long-Term Care Medicine. Template for an Antibiotic Stewardship Policy for Post-Acute and Long-Term Care Settings. J Am Med Dir Assoc 2017;18:913-20. [PMID: 28935515 DOI: 10.1016/j.jamda.2017.07.018] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
37 Tamma PD, Miller MA, Dullabh P, Ahn R, Speck K, Gao Y, Scherpf E, Cosgrove SE. Association of a Safety Program for Improving Antibiotic Use With Antibiotic Use and Hospital-Onset Clostridioides difficile Infection Rates Among US Hospitals. JAMA Netw Open 2021;4:e210235. [PMID: 33635327 DOI: 10.1001/jamanetworkopen.2021.0235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Sinclair A, Xie X, Saab L, Dendukuri N. Lactobacillus probiotics in the prevention of diarrhea associated with Clostridium difficile: a systematic review and Bayesian hierarchical meta-analysis. CMAJ Open 2016;4:E706-18. [PMID: 28018885 DOI: 10.9778/cmajo.20160087] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
39 Becker DE. Adverse drug reactions in dental practice. Anesth Prog 2014;61:26-33; quiz 34. [PMID: 24697823 DOI: 10.2344/0003-3006-61.1.26] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
40 Jump RLP, Crnich CJ, Mody L, Bradley SF, Nicolle LE, Yoshikawa TT. Infectious Diseases in Older Adults of Long-Term Care Facilities: Update on Approach to Diagnosis and Management. J Am Geriatr Soc 2018;66:789-803. [PMID: 29667186 DOI: 10.1111/jgs.15248] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 10.0] [Reference Citation Analysis]
41 Budgell EP, Davies T, Donker T, Hopkins S, Wyllie D, Peto TEA, Gill M, Llewelyn MJ, Walker AS. Impact of hospital antibiotic use on patient-level risk of death among 36,124,372 acute and medical admissions in England. J Infect 2021:S0163-4453(21)00648-4. [PMID: 34963640 DOI: 10.1016/j.jinf.2021.12.029] [Reference Citation Analysis]
42 Segal JP, Poo SX, McLaughlin SD, Faiz OD, Clark SK, Hart AL. Long-term follow-up of the use of maintenance antibiotic therapy for chronic antibiotic-dependent pouchitis. Frontline Gastroenterol 2018;9:154-8. [PMID: 29588846 DOI: 10.1136/flgastro-2017-100913] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.8] [Reference Citation Analysis]
43 Mamo Y, Woodworth MH, Wang T, Dhere T, Kraft CS. Durability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection. Clin Infect Dis 2018;66:1705-11. [PMID: 29272401 DOI: 10.1093/cid/cix1097] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
44 Di Bella S, Taglietti F, Petrosillo N. Are there reasons to prefer tetracyclines to macrolides in older patients with community-acquired pneumonia? Antimicrob Agents Chemother 2013;57:4093. [PMID: 23858063 DOI: 10.1128/AAC.00828-13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
45 DeRogatis MJ, Mahon AM, Lee P, Issack PS. Perioperative Considerations to Reduce Infection Risk in Primary Total Hip and Knee Arthroplasty. JBJS Rev 2018;6:e8. [PMID: 29664871 DOI: 10.2106/JBJS.RVW.17.00144] [Reference Citation Analysis]
46 Strohäker J, Bareiß S, Nadalin S, Königsrainer A, Ladurner R, Meier A. The Prevalence and Clinical Significance of Anaerobic Bacteria in Major Liver Resection. Antibiotics (Basel) 2021;10:139. [PMID: 33572541 DOI: 10.3390/antibiotics10020139] [Reference Citation Analysis]
47 Jose S, Madan R. Neutrophil-mediated inflammation in the pathogenesis of Clostridium difficile infections. Anaerobe 2016;41:85-90. [PMID: 27063896 DOI: 10.1016/j.anaerobe.2016.04.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
48 Shover CL, Beymer MR, Unger EM, Javanbakht M, Bolan RK. Accuracy of Presumptive Gonorrhea Treatment for Gay, Bisexual, and Other Men Who Have Sex with Men: Results from a Large Sexual Health Clinic in Los Angeles, California. LGBT Health 2018;5:139-44. [PMID: 29493405 DOI: 10.1089/lgbt.2017.0115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
49 Collins CE, Ayturk MD, Flahive JM, Emhoff TA, Anderson FA Jr, Santry HP. Epidemiology and outcomes of community-acquired Clostridium difficile infections in Medicare beneficiaries. J Am Coll Surg 2014;218:1141-1147.e1. [PMID: 24755188 DOI: 10.1016/j.jamcollsurg.2014.01.053] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
50 Ghia CJ, Waghela S, Rambhad GS. Systematic Literature Review on Burden of Clostridioides difficile Infection in India. Clin Pathol 2021;14:2632010X211013816. [PMID: 34104883 DOI: 10.1177/2632010X211013816] [Reference Citation Analysis]
51 Woodworth MH, Carpentieri C, Sitchenko KL, Kraft CS. Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review. Gut Microbes. 2017;8:225-237. [PMID: 28129018 DOI: 10.1080/19490976.2017.1286006] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 9.2] [Reference Citation Analysis]
52 Abramavicius S, Stundziene A, Jankauskaite L, Vitkauskiene A, Kowalski IM, Wojtkiewicz J, Stankevicius E. Novel approach towards antimicrobial chemotherapy optimization in lower respiratory tract infections in children: An observational study. Medicine (Baltimore) 2021;100:e26585. [PMID: 34596107 DOI: 10.1097/MD.0000000000026585] [Reference Citation Analysis]
53 Faggion PI, Isoton G, Possa E, Tasso L. Is the penetration of clindamycin into the masseter muscle really enough to treat odontogenic infections? Clin Oral Investig 2021;25:3257-66. [PMID: 33128135 DOI: 10.1007/s00784-020-03656-z] [Reference Citation Analysis]
54 Auchtung JM, Preisner EC, Collins J, Lerma AI, Britton RA. Identification of Simplified Microbial Communities That Inhibit Clostridioides difficile Infection through Dilution/Extinction. mSphere 2020;5:e00387-20. [PMID: 32727857 DOI: 10.1128/mSphere.00387-20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
55 Lim SC, Hain-Saunders NMR, Imwattana K, Putsathit P, Collins DA, Riley TV. Genetically related Clostridium difficile from water sources and human CDI cases revealed by whole-genome sequencing. Environ Microbiol 2021. [PMID: 34693624 DOI: 10.1111/1462-2920.15821] [Reference Citation Analysis]
56 Tandan M, Burns K, Murphy H, Hennessy S, Cormican M, Vellinga A. Antimicrobial prescribing and infections in long-term care facilities (LTCF): a multilevel analysis of the HALT 2016 study, Ireland, 2017. Euro Surveill 2018;23. [PMID: 30458910 DOI: 10.2807/1560-7917.ES.2018.23.46.1800278] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
57 Milosavljevic MN, Kostic M, Milovanovic J, Zaric RZ, Stojadinovic M, Jankovic SM, Stefanovic SM. Antimicrobial treatment of Erysipelatoclostridium ramosum invasive infections: a systematic review. Rev Inst Med Trop Sao Paulo 2021;63:e30. [PMID: 33852713 DOI: 10.1590/S1678-9946202163030] [Reference Citation Analysis]
58 Antonelli M, Martin-Loeches I, Dimopoulos G, Gasbarrini A, Vallecoccia MS. Clostridioides difficile (formerly Clostridium difficile) infection in the critically ill: an expert statement. Intensive Care Med 2020;46:215-24. [PMID: 31938827 DOI: 10.1007/s00134-019-05873-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Smith DR, Temime L, Opatowski L. Microbiome-pathogen interactions drive epidemiological dynamics of antibiotic resistance: A modeling study applied to nosocomial pathogen control. Elife 2021;10:e68764. [PMID: 34517942 DOI: 10.7554/eLife.68764] [Reference Citation Analysis]
60 Bogaert D, van Belkum A. Antibiotic treatment and stewardship in the era of microbiota-oriented diagnostics. Eur J Clin Microbiol Infect Dis 2018;37:795-8. [PMID: 29411188 DOI: 10.1007/s10096-018-3198-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
61 Klarin B, Larsson A, Molin G, Jeppsson B. Susceptibility to antibiotics in isolates of Lactobacillus plantarum RAPD-type Lp299v, harvested from antibiotic treated, critically ill patients after administration of probiotics. Microbiologyopen 2019;8:e00642. [PMID: 29797784 DOI: 10.1002/mbo3.642] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
62 Al-Hasan MN, Winders HR, Bookstaver PB, Justo JA. Direct Measurement of Performance: A New Era in Antimicrobial Stewardship. Antibiotics (Basel) 2019;8:E127. [PMID: 31450576 DOI: 10.3390/antibiotics8030127] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
63 Silvetti S, Landoni G. Is Clostridium difficile the new bugaboo after cardiac surgery? J Thorac Dis 2018;10:S3278-80. [PMID: 30370137 DOI: 10.21037/jtd.2018.08.99] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
64 Lau CS, Chamberlain RS. Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Int J Gen Med. 2016;9:27-37. [PMID: 26955289 DOI: 10.2147/ijgm.s98280] [Cited by in Crossref: 28] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
65 Panwar RB, Sequeira RP, Clarke TB. Microbiota-mediated protection against antibiotic-resistant pathogens. Genes Immun 2021. [PMID: 33947987 DOI: 10.1038/s41435-021-00129-5] [Reference Citation Analysis]
66 Vrbanac A, Patras KA, Jarmusch AK, Mills RH, Shing SR, Quinn RA, Vargas F, Gonzalez DJ, Dorrestein PC, Knight R, Nizet V. Evaluating Organism-Wide Changes in the Metabolome and Microbiome following a Single Dose of Antibiotic. mSystems 2020;5:e00340-20. [PMID: 33024048 DOI: 10.1128/mSystems.00340-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Islam R, Weir CR, Jones M, Del Fiol G, Samore MH. Understanding complex clinical reasoning in infectious diseases for improving clinical decision support design. BMC Med Inform Decis Mak 2015;15:101. [PMID: 26620881 DOI: 10.1186/s12911-015-0221-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
68 Cugini C, Ramasubbu N, Tsiagbe VK, Fine DH. Dysbiosis From a Microbial and Host Perspective Relative to Oral Health and Disease. Front Microbiol 2021;12:617485. [PMID: 33763040 DOI: 10.3389/fmicb.2021.617485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
69 Babowicz F, LaPlante R, Mitchell C, O'Donnell JN, Tobin E, George M, Carreno JJ. Impact of Accelerate Pheno and BacT/Alert Virtuo on Clinical Processes and Outcomes in Patients with Sepsis and Concurrent Gram-Negative Bacteremia. Antimicrob Agents Chemother 2021;65:e02364-20. [PMID: 33753337 DOI: 10.1128/AAC.02364-20] [Reference Citation Analysis]
70 Collins J, Auchtung JM. Control of Clostridium difficile Infection by Defined Microbial Communities. Microbiol Spectr 2017;5. [PMID: 28936948 DOI: 10.1128/microbiolspec.BAD-0009-2016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
71 Walsh TL, Taffe K, Sacca N, Bremmer DN, Sealey ML, Cuevas E, Johnston A, Malarkey A, Behr R, Embrescia J, Sahota E, Loucks S, Gupta N, Shields KJ, Katz C, Kapetanos A. Risk Factors for Unnecessary Antibiotic Prescribing for Acute Respiratory Tract Infections in Primary Care. Mayo Clin Proc Innov Qual Outcomes 2020;4:31-9. [PMID: 32055769 DOI: 10.1016/j.mayocpiqo.2019.09.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
72 Schwartz KL, Langford BJ, Daneman N, Chen B, Brown KA, McIsaac W, Tu K, Candido E, Johnstone J, Leung V, Hwee J, Silverman M, Wu JHC, Garber G. Unnecessary antibiotic prescribing in a Canadian primary care setting: a descriptive analysis using routinely collected electronic medical record data. CMAJ Open 2020;8:E360-9. [PMID: 32381687 DOI: 10.9778/cmajo.20190175] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
73 Kandel CE, Gill S, McCready J, Matelski J, Powis JE. Reducing co-administration of proton pump inhibitors and antibiotics using a computerized order entry alert and prospective audit and feedback. BMC Infect Dis 2016;16:355. [PMID: 27449956 DOI: 10.1186/s12879-016-1679-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
74 Becerra MB, Becerra BJ, Banta JE, Safdar N. Impact of Clostridium difficile infection among pneumonia and urinary tract infection hospitalizations: an analysis of the Nationwide Inpatient Sample. BMC Infect Dis 2015;15:254. [PMID: 26126606 DOI: 10.1186/s12879-015-0925-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
75 Wilcox MH, Chalmers JD, Nord CE, Freeman J, Bouza E. Role of cephalosporins in the era of Clostridium difficile infection. J Antimicrob Chemother 2017;72:1-18. [PMID: 27659735 DOI: 10.1093/jac/dkw385] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
76 Milani C, Ticinesi A, Gerritsen J, Nouvenne A, Lugli GA, Mancabelli L, Turroni F, Duranti S, Mangifesta M, Viappiani A, Ferrario C, Maggio M, Lauretani F, De Vos W, van Sinderen D, Meschi T, Ventura M. Gut microbiota composition and Clostridium difficile infection in hospitalized elderly individuals: a metagenomic study. Sci Rep 2016;6:25945. [PMID: 27166072 DOI: 10.1038/srep25945] [Cited by in Crossref: 118] [Cited by in F6Publishing: 105] [Article Influence: 19.7] [Reference Citation Analysis]
77 Shahi F, Redeker K, Chong J. Rethinking antimicrobial stewardship paradigms in the context of the gut microbiome. JAC Antimicrob Resist 2019;1:dlz015. [PMID: 34222889 DOI: 10.1093/jacamr/dlz015] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
78 Fox MT, Melia MT, Same RG, Conley AT, Tamma PD. A Seven-Day Course of TMP-SMX May Be as Effective as a Seven-Day Course of Ciprofloxacin for the Treatment of Pyelonephritis. Am J Med 2017;130:842-5. [PMID: 28216442 DOI: 10.1016/j.amjmed.2017.01.025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
79 Othman F, Crooks CJ, Card TR. The risk of Clostridium difficile infection in patients with pernicious anaemia: a retrospective cohort study using primary care database. United European Gastroenterol J 2017;5:959-66. [PMID: 29163961 DOI: 10.1177/2050640617695697] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
80 Frost HM, Munsiff SS, Lou Y, Jenkins TC. Simplifying outpatient antibiotic stewardship. Infect Control Hosp Epidemiol 2021;:1-2. [PMID: 33517928 DOI: 10.1017/ice.2020.1409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
81 Bongers S, Hellebrekers P, Leenen LPH, Koenderman L, Hietbrink F. Intracellular Penetration and Effects of Antibiotics on Staphylococcus aureus Inside Human Neutrophils: A Comprehensive Review. Antibiotics (Basel) 2019;8:E54. [PMID: 31060222 DOI: 10.3390/antibiotics8020054] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
82 Predrag S, Branislava K, Nikola S, Niko R, Zorica SR, Stanković-Đorđević D. Community-acquired Clostridium difficile infection in Serbian pediatric population. Eur J Clin Microbiol Infect Dis 2018;37:1061-9. [PMID: 29497879 DOI: 10.1007/s10096-018-3218-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
83 Karasov TL, Almario J, Friedemann C, Ding W, Giolai M, Heavens D, Kersten S, Lundberg DS, Neumann M, Regalado J, Neher RA, Kemen E, Weigel D. Arabidopsis thaliana and Pseudomonas Pathogens Exhibit Stable Associations over Evolutionary Timescales. Cell Host Microbe 2018;24:168-179.e4. [PMID: 30001519 DOI: 10.1016/j.chom.2018.06.011] [Cited by in Crossref: 75] [Cited by in F6Publishing: 51] [Article Influence: 25.0] [Reference Citation Analysis]
84 Ackah JK, Neal L, Marshall NR, Panahi P, Lloyd C, Rogers LJ. Antimicrobial prophylaxis in adult cardiac surgery in the United Kingdom and Republic of Ireland. J Infect Prev 2021;22:83-90. [PMID: 33859725 DOI: 10.1177/1757177420971850] [Reference Citation Analysis]
85 Tan C, Graves E, Lu H, Chen A, Li S, Schwartz KL, Daneman N. A decade of outpatient antimicrobial use in older adults in Ontario: a descriptive study. CMAJ Open 2017;5:E878-85. [PMID: 29273579 DOI: 10.9778/cmajo.20170100] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
86 Ho J, Dai RZW, Kwong TNY, Wang X, Zhang L, Ip M, Chan R, Hawkey PMK, Lam KLY, Wong MCS, Tse G, Chan MTV, Chan FKL, Yu J, Ng SC, Lee N, Wu JCY, Sung JJY, Wu WKK, Wong SH. Disease Burden of Clostridium difficile Infections in Adults, Hong Kong, China, 2006-2014. Emerg Infect Dis 2017;23:1671-9. [PMID: 28930010 DOI: 10.3201/eid2310.170797] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
87 Langford BJ, Chen C, Daneman N, Brown KA, Gomes T, Johnstone J, Wu J, Leung V, Garber G, Schwartz KL. Concordance between high antibiotic prescribing and high opioid prescribing among primary care physicians: a cross-sectional study. CMAJ Open 2021;9:E175-80. [PMID: 33688025 DOI: 10.9778/cmajo.20200122] [Reference Citation Analysis]
88 de Gunzburg J, Ghozlane A, Ducher A, Le Chatelier E, Duval X, Ruppé E, Armand-Lefevre L, Sablier-Gallis F, Burdet C, Alavoine L, Chachaty E, Augustin V, Varastet M, Levenez F, Kennedy S, Pons N, Mentré F, Andremont A. Protection of the Human Gut Microbiome From Antibiotics. J Infect Dis 2018;217:628-36. [PMID: 29186529 DOI: 10.1093/infdis/jix604] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 22.0] [Reference Citation Analysis]
89 Wang PW, Lee WT, Wu YN, Shieh DB. Opportunities for Nanomedicine in Clostridioides difficile Infection. Antibiotics (Basel) 2021;10:948. [PMID: 34438998 DOI: 10.3390/antibiotics10080948] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Miller AC, Segre AM, Pemmaraju SV, Sewell DK, Polgreen PM. Association of Household Exposure to Primary Clostridioides difficile Infection With Secondary Infection in Family Members. JAMA Netw Open 2020;3:e208925. [PMID: 32589232 DOI: 10.1001/jamanetworkopen.2020.8925] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
91 Moura IB, Buckley AM, Ewin D, Shearman S, Clark E, Wilcox MH, Chilton CH. Omadacycline Gut Microbiome Exposure Does Not Induce Clostridium difficile Proliferation or Toxin Production in a Model That Simulates the Proximal, Medial, and Distal Human Colon. Antimicrob Agents Chemother 2019;63:e01581-18. [PMID: 30455242 DOI: 10.1128/AAC.01581-18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
92 Gupta A, Khanna S. Community-acquired Clostridium difficile infection: an increasing public health threat. Infect Drug Resist 2014;7:63-72. [PMID: 24669194 DOI: 10.2147/IDR.S46780] [Cited by in Crossref: 22] [Cited by in F6Publishing: 66] [Article Influence: 2.8] [Reference Citation Analysis]
93 Eze P, Balsells E, Kyaw MH, Nair H. Risk factors for Clostridium difficile infections - an overview of the evidence base and challenges in data synthesis. J Glob Health 2017;7:010417. [PMID: 28607673 DOI: 10.7189/jogh.07.010417] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 12.3] [Reference Citation Analysis]
94 Kirkpatrick C, Haynes A, Sharma P. Antibiotic prophylaxis is not associated with reduced urinary tract infection-related complications after cystectomy and ileal conduit. Bladder (San Franc) 2018;5:e35. [PMID: 32775477 DOI: 10.14440/bladder.2018.722] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
95 Keats KR, Stitt TM, Chastain DB, Jivan BP, Matznick E, Waller JL, Clemmons AB. Evaluating Clostridioides difficile infection (CDI) treatment duration in hematology/oncology patients receiving concurrent non-CDI antibiotics. J Oncol Pharm Pract 2021;:1078155221998735. [PMID: 33663290 DOI: 10.1177/1078155221998735] [Reference Citation Analysis]
96 Al-Tawil K, Babu A, Loeffler M, Williams T. Second generation cephalosporin antibiotic prophylaxis and Clostridium difficile infection in hip and knee arthroplasty. Ann R Coll Surg Engl 2017;99:351-4. [PMID: 28462657 DOI: 10.1308/rcsann.2017.0025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
97 Davis J, Umeh U, Saba R. Treatment of SARS-CoV-2 (COVID-19): A safety perspective. World J Pharmacol 2021; 10(1): 1-32 [DOI: 10.5497/wjp.v10.i1.1] [Reference Citation Analysis]
98 Walsh TL, Chan L, Konopka CI, Burkitt MJ, Moffa MA, Bremmer DN, Murillo MA, Watson C, Chan-Tompkins NH. Appropriateness of antibiotic management of uncomplicated skin and soft tissue infections in hospitalized adult patients. BMC Infect Dis 2016;16:721. [PMID: 27899072 DOI: 10.1186/s12879-016-2067-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
99 Stewart D, Romo JA, Lamendella R, Kumamoto CA. The role of fungi in C. difficile infection: An underappreciated transkingdom interaction. Fungal Genet Biol 2019;129:1-6. [PMID: 30978391 DOI: 10.1016/j.fgb.2019.04.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
100 Tandan M, O'Connor R, Burns K, Murphy H, Hennessy S, Roche F, Donlon S, Cormican M, Vellinga A. A comparative analysis of prophylactic antimicrobial use in long-term care facilities in Ireland, 2013 and 2016. Euro Surveill 2019;24. [PMID: 30892182 DOI: 10.2807/1560-7917.ES.2019.24.11.1800102] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
101 Cojocariu C, Girleanu I, Trifan A, Olteanu A, Muzica CM, Huiban L, Chiriac S, Singeap AM, Cuciureanu T, Sfarti C, Stanciu C. Did the severe acute respiratory syndrome-coronavirus 2 pandemic cause an endemic Clostridium difficile infection? World J Clin Cases 2021; 9(33): 10180-10188 [PMID: 34904088 DOI: 10.12998/wjcc.v9.i33.10180] [Reference Citation Analysis]
102 Jones-Nelson O, Tovchigrechko A, Glover MS, Fernandes F, Rangaswamy U, Liu H, Tabor DE, Boyd J, Warrener P, Martinez J, Hilliard JJ, Stover CK, Yu W, DAngelo G, Hess S, Cohen TS, Sellman BR. Antibacterial Monoclonal Antibodies Do Not Disrupt the Intestinal Microbiome or Its Function. Antimicrob Agents Chemother 2020;64:e02347-19. [PMID: 32152087 DOI: 10.1128/AAC.02347-19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Ge IY, Fevrier HB, Conell C, Kheraj MN, Flint AC, Smith DS, Herrinton LJ. Reducing risk of Clostridium difficile infection and overall use of antibiotic in the outpatient treatment of urinary tract infection. Ther Adv Urol 2018;10:283-93. [PMID: 30186366 DOI: 10.1177/1756287218783871] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
104 Lam PW, Graham C, Leis JA, Daneman N. Predictors of Peripherally Inserted Central Catheter Occlusion in the Outpatient Parenteral Antimicrobial Therapy Setting. Antimicrob Agents Chemother 2018;62:e00900-18. [PMID: 29967016 DOI: 10.1128/AAC.00900-18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
105 Farshidfar N, Hamedani S, Amiri MA, Tovani-Palone MR, Nemati S. Modifications to the 2021 American Heart Association guideline for antibiotic prophylaxis prior to invasive dental procedures: Strengths and pitfalls. Spec Care Dentist 2021. [PMID: 34591993 DOI: 10.1111/scd.12655] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Skoutelis A, Pefanis A, Tsiodras S, Sipsas NV, Lelekis M, Lazanas MC, Gargalianos P, Dalekos GN, Roilides E, Samonis G, Maltezos E, Hatzigeorgiou D, Lada M, Metallidis S, Stoupis A, Chrysos G, Karnesis L, Symbardi S, Loupa CV, Giamarellou H, Kioumis I, Sambatakou H, Tsianos E, Kotsopoulou M, Georgopali A, Liakou K, Perlorentzou S, Levidiotou S, Giotsa-Toutouza M, Tsorlini-Christoforidou H, Karaiskos I, Kouppari G, Trikka-Graphakos E, Ntrivala MA, Themeli-Digalaki K, Pangalis A, Kachrimanidou M, Martsoukou M, Karapsias S, Panopoulou M, Maraki S, Orfanou A, Petinaki E, Orfanidou M, Baka V, Stylianakis A, Spiliopoulou I, Smilakou S, Zerva L, Vogiatzakis E, Belesiotou E, Gogos CA. Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study. PLoS One 2017;12:e0182799. [PMID: 28813492 DOI: 10.1371/journal.pone.0182799] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
107 Tydeman F, Craine N, Kavanagh K, Adams H, Reynolds R, McClure V, Hughes H, Hickman M, Robertson C. Incidence of Clostridioides difficile infection (CDI) related to antibiotic prescribing by GP surgeries in Wales. J Antimicrob Chemother 2021:dkab204. [PMID: 34151964 DOI: 10.1093/jac/dkab204] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Evans LE, Krishna A, Ma Y, Webb TE, Marshall DC, Tooke CL, Spencer J, Clarke TB, Armstrong A, Edwards AM. Exploitation of Antibiotic Resistance as a Novel Drug Target: Development of a β-Lactamase-Activated Antibacterial Prodrug. J Med Chem 2019;62:4411-25. [PMID: 31009558 DOI: 10.1021/acs.jmedchem.8b01923] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
109 Warren DK, Peacock KM, Nickel KB, Fraser VJ, Olsen MA; CDC Prevention Epicenter Program. Postdischarge prophylactic antibiotics following mastectomy with and without breast reconstruction. Infect Control Hosp Epidemiol 2021;:1-7. [PMID: 34569458 DOI: 10.1017/ice.2021.400] [Reference Citation Analysis]
110 Gross AE, Khouja T, Rowan SA, Suda KJ. Unnecessary Antibiotic Prescribing in Dental Practices and Associated Adverse Effects. Curr Infect Dis Rep 2021;23. [DOI: 10.1007/s11908-021-00751-4] [Reference Citation Analysis]
111 Zhou Y, Burnham CA, Hink T, Chen L, Shaikh N, Wollam A, Sodergren E, Weinstock GM, Tarr PI, Dubberke ER. Phenotypic and genotypic analysis of Clostridium difficile isolates: a single-center study. J Clin Microbiol 2014;52:4260-6. [PMID: 25275005 DOI: 10.1128/JCM.02115-14] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
112 Teng C, Reveles KR, Obodozie-Ofoegbu OO, Frei CR. Clostridium difficile Infection Risk with Important Antibiotic Classes: An Analysis of the FDA Adverse Event Reporting System. Int J Med Sci 2019;16:630-5. [PMID: 31217729 DOI: 10.7150/ijms.30739] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
113 Milano A, Sulejmani A, Intra J, Sala MR, Leoni V, Carcione D. Antimicrobial Resistance Trends of Escherichia coli Isolates from Outpatient and Inpatient Urinary Infections over a 20-Year Period. Microb Drug Resist 2021. [PMID: 34520265 DOI: 10.1089/mdr.2021.0010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Meryk A, Kropshofer G, Bargehr C, Knoll M, Hetzer B, Lass-Flörl C, Crazzolara R. Which Type of Empiric Antibiotic Therapy is Appropriate? A 20-Year Retrospective Study of Bloodstream Infections in Childhood Cancer. Infect Dis Ther 2021;10:789-800. [PMID: 33704685 DOI: 10.1007/s40121-021-00427-5] [Reference Citation Analysis]
115 Zacharioudakis IM, Zervou FN, Shehadeh F, Mylona EK, Mylonakis E. Association of Community Factors with Hospital-onset Clostridioides (Clostridium) difficile Infection: A Population Based U.S.-wide Study. EClinicalMedicine 2019;8:12-9. [PMID: 31193719 DOI: 10.1016/j.eclinm.2019.02.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
116 Jenior ML, Leslie JL, Young VB, Schloss PD. Clostridium difficile Alters the Structure and Metabolism of Distinct Cecal Microbiomes during Initial Infection To Promote Sustained Colonization. mSphere 2018;3:e00261-18. [PMID: 29950381 DOI: 10.1128/mSphere.00261-18] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
117 Thornhill MH, Dayer MJ, Durkin MJ, Lockhart PB, Baddour LM. Oral antibiotic prescribing by NHS dentists in England 2010-2017. Br Dent J 2019;227:1044-50. [PMID: 31873263 DOI: 10.1038/s41415-019-1002-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
118 Sandhu A, Tillotson G, Polistico J, Salimnia H, Cranis M, Moshos J, Cullen L, Jabbo L, Diebel L, Chopra T. Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020. Emerg Infect Dis 2020;26. [PMID: 32441243 DOI: 10.3201/eid2609.202126] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 12.0] [Reference Citation Analysis]
119 Diener C, Hoge ACH, Kearney SM, Kusebauch U, Patwardhan S, Moritz RL, Erdman SE, Gibbons SM. Non-responder phenotype reveals apparent microbiome-wide antibiotic tolerance in the murine gut. Commun Biol 2021;4:316. [PMID: 33750910 DOI: 10.1038/s42003-021-01841-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
120 Cusumano JA, Hermenau M, Gaitanis M, Travis M, LaPlante KL, Tran TY, McConeghy KW. Evaluation of post-flexible cystoscopy urinary tract infection rates. Am J Health Syst Pharm 2020;77:1852-8. [PMID: 32827037 DOI: 10.1093/ajhp/zxaa270] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
121 Takahashi M, Mori N, Bito S. Multi-institution case-control and cohort study of risk factors for the development and mortality of Clostridium difficile infections in Japan. BMJ Open. 2014;4:e005665. [PMID: 25186155 DOI: 10.1136/bmjopen-2014-005665] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
122 Ochoa-Hein E, Sifuentes-Osornio J, Ponce de León-Garduño A, Torres-González P, Granados-García V, Galindo-Fraga A. Factors associated with an outbreak of hospital-onset, healthcare facility-associated Clostridium difficile infection (HO-HCFA CDI) in a Mexican tertiary care hospital: A case-control study. PLoS One 2018;13:e0198212. [PMID: 29813115 DOI: 10.1371/journal.pone.0198212] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
123 Lal A, Davaro R, Mishra AK, Sahu KK, Abraham GM. Detection of coexisting toxigenic Clostridium difficile and nontyphoidal Salmonella in a healthcare worker with diarrhea: A therapeutic dilemma. J Family Med Prim Care 2019;8:2724-7. [PMID: 31548964 DOI: 10.4103/jfmpc.jfmpc_227_19] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
124 Predrag S, Kuijper EJ, Nikola S, Vendrik KEW, Niko R. Recurrent community-acquired Clostridium(Clostridioides)difficile infection in Serbianchildren. Eur J Clin Microbiol Infect Dis 2020;39:509-16. [PMID: 31713000 DOI: 10.1007/s10096-019-03751-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
125 Zhou MJ, Li J, Salmasian H, Zachariah P, Yang YX, Freedberg DE. The local hospital milieu and healthcare-associated vancomycin-resistant enterococcus acquisition. J Hosp Infect 2019;101:69-75. [PMID: 30026006 DOI: 10.1016/j.jhin.2018.07.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
126 Lee HS, Plechot K, Gohil S, Le J. Clostridium difficile: Diagnosis and the Consequence of Over Diagnosis. Infect Dis Ther 2021;10:687-97. [PMID: 33770398 DOI: 10.1007/s40121-021-00417-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
127 Lee HY, Hsiao HL, Chia CY, Cheng CW, Tsai TC, Deng ST, Chen CL, Chiu CH. Risk factors and outcomes of Clostridium difficile infection in hospitalized patients. Biomed J 2019;42:99-106. [PMID: 31130254 DOI: 10.1016/j.bj.2018.12.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
128 Xu X, Godoy-Ruiz R, Adipietro KA, Peralta C, Ben-Hail D, Varney KM, Cook ME, Roth BM, Wilder PT, Cleveland T, Grishaev A, Neu HM, Michel SLJ, Yu W, Beckett D, Rustandi RR, Lancaster C, Loughney JW, Kristopeit A, Christanti S, Olson JW, MacKerell AD, Georges AD, Pozharski E, Weber DJ. Structure of the cell-binding component of the Clostridium difficile binary toxin reveals a di-heptamer macromolecular assembly. Proc Natl Acad Sci U S A 2020;117:1049-58. [PMID: 31896582 DOI: 10.1073/pnas.1919490117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
129 Marion S, Desharnais L, Studer N, Dong Y, Notter MD, Poudel S, Menin L, Janowczyk A, Hettich RL, Hapfelmeier S, Bernier-Latmani R. Biogeography of microbial bile acid transformations along the murine gut. J Lipid Res 2020;61:1450-63. [PMID: 32661017 DOI: 10.1194/jlr.RA120001021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
130 Miller AC, Sewell DK, Segre AM, Pemmaraju SV, Polgreen PM. Risk for Clostridioides difficile Infection Among Hospitalized Patients Associated With Multiple Healthcare Exposures Prior to Admission. J Infect Dis 2021;224:684-94. [PMID: 33340038 DOI: 10.1093/infdis/jiaa773] [Reference Citation Analysis]
131 Smith AB, Soto Ocana J, Zackular JP. From Nursery to Nursing Home: Emerging Concepts in Clostridioides difficile Pathogenesis. Infect Immun 2020;88:e00934-19. [PMID: 32122939 DOI: 10.1128/IAI.00934-19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
132 Brown KA, Langford B, Schwartz KL, Diong C, Garber G, Daneman N. Antibiotic Prescribing Choices and Their Comparative C. Difficile Infection Risks: A Longitudinal Case-Cohort Study. Clin Infect Dis 2021;72:836-44. [PMID: 32069358 DOI: 10.1093/cid/ciaa124] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
133 Martin LT, Vincent S, Gillian S, Moore K, Ratermann D, Droege CA. Pharmacologic Approach to Management of Clostridium difficile Infection. Crit Care Nurs Q 2019;42:2-11. [PMID: 30507659 DOI: 10.1097/CNQ.0000000000000232] [Reference Citation Analysis]
134 Bruns N, Dohna-Schwake C. Antibiotics in critically ill children-a narrative review on different aspects of a rational approach. Pediatr Res 2021. [PMID: 34873285 DOI: 10.1038/s41390-021-01878-9] [Reference Citation Analysis]
135 Lodise T, Rodriguez M, Chitra S, Wright K, Patel N. Potential Cost Savings Associated with Targeted Substitution of Current Guideline-Concordant Inpatient Agents with Omadacycline for the Treatment of Adult Hospitalized Patients with Community-Acquired Bacterial Pneumonia at High Risk for Clostridioides difficile Infections: Results of Healthcare-Decision Analytic Model from the United States Hospital Perspective. Antibiotics (Basel) 2021;10:1195. [PMID: 34680776 DOI: 10.3390/antibiotics10101195] [Reference Citation Analysis]
136 Kester JC, Brubaker DK, Velazquez J, Wright C, Lauffenburger DA, Griffith LG. Clostridioides difficile-Associated Antibiotics Alter Human Mucosal Barrier Functions by Microbiome-Independent Mechanisms. Antimicrob Agents Chemother 2020;64:e01404-19. [PMID: 31988098 DOI: 10.1128/AAC.01404-19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
137 Anomaly J. The Future of Phage: Ethical Challenges of Using Phage Therapy to Treat Bacterial Infections. Public Health Ethics 2020;13:82-8. [PMID: 32760449 DOI: 10.1093/phe/phaa003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
138 Maghdoori S, Moghadas SM. Assessing the effect of patient screening and isolation on curtailing Clostridium difficile infection in hospital settings. BMC Infect Dis 2017;17:384. [PMID: 28577357 DOI: 10.1186/s12879-017-2494-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
139 Cotter KJ, Fan Y, Sieger GK, Weight CJ, Konety BR. Prevalence of Clostridium Difficile Infection in Patients After Radical Cystectomy and Neoadjuvant Chemotherapy. Bladder Cancer 2017;3:305-10. [PMID: 29152554 DOI: 10.3233/BLC-170132] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
140 Bätzing-Feigenbaum J, Schulz M, Schulz M, Hering R, Kern WV. Outpatient Antibiotic Prescription. Dtsch Arztebl Int 2016;113:454-9. [PMID: 27412990 DOI: 10.3238/arztebl.2016.0454] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
141 DuPont HL. Challenges and opportunities in the management of Clostridium difficile infection. Expert Rev Gastroenterol Hepatol 2014;8:863-74. [PMID: 25012255 DOI: 10.1586/17474124.2014.939630] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
142 Simmering JE, Polgreen LA, Campbell DR, Cavanaugh JE, Polgreen PM. Hospital Transfer Network Structure as a Risk Factor for Clostridium difficile Infection. Infect Control Hosp Epidemiol 2015;36:1031-7. [PMID: 26072907 DOI: 10.1017/ice.2015.130] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
143 Marttila-Vaara M, Ylipalosaari P, Kauma H. Clostridium difficile infections in teaching hospital in northern Finland. BMC Infect Dis 2019;19:48. [PMID: 30634939 DOI: 10.1186/s12879-018-3663-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
144 Thornhill MH, Dayer MJ, Durkin MJ, Lockhart PB, Baddour LM. Risk of Adverse Reactions to Oral Antibiotics Prescribed by Dentists. J Dent Res 2019;98:1081-7. [PMID: 31314998 DOI: 10.1177/0022034519863645] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
145 Farshidfar N, Hamedani S, Amiri MA, Tovani‐palone MR, Nemati S. Modifications to the 2021 American Heart Association guideline for antibiotic prophylaxis prior to invasive dental procedures: Strengths and pitfalls. Spec Care Dentist. [DOI: 10.1111/scd.12655] [Reference Citation Analysis]
146 Stoesser N, Eyre DW, Quan TP, Godwin H, Pill G, Mbuvi E, Vaughan A, Griffiths D, Martin J, Fawley W, Dingle KE, Oakley S, Wanelik K, Finney JM, Kachrimanidou M, Moore CE, Gorbach S, Riley TV, Crook DW, Peto TEA, Wilcox MH, Walker AS; Modernising Medical Microbiology Informatics Group (MMMIG). Epidemiology of Clostridium difficile in infants in Oxfordshire, UK: Risk factors for colonization and carriage, and genetic overlap with regional C. difficile infection strains. PLoS One 2017;12:e0182307. [PMID: 28813461 DOI: 10.1371/journal.pone.0182307] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 9.4] [Reference Citation Analysis]
147 Singh T, Bedi P, Bumrah K, Singh J, Rai M, Seelam S. Updates in Treatment of Recurrent Clostridium difficile Infection. J Clin Med Res. 2019;11:465-471. [PMID: 31236163 DOI: 10.14740/jocmr3854] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
148 Larrainzar-Coghen T, Rodriguez-Pardo D, Puig-Asensio M, Rodríguez V, Ferrer C, Bartolomé R, Pigrau C, Fernández-Hidalgo N, Pumarola T, Almirante B. First recurrence of Clostridium difficile infection: clinical relevance, risk factors, and prognosis. Eur J Clin Microbiol Infect Dis 2016;35:371-8. [PMID: 26753991 DOI: 10.1007/s10096-015-2549-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
149 Aldrete Sdel M, Magee MJ, Friedman-Moraco RJ, Chan AW, Banks GG, Burd EM, Kraft CS. Characteristics and Antibiotic Use Associated With Short-Term Risk of Clostridium difficile Infection Among Hospitalized Patients. Am J Clin Pathol 2015;143:895-900. [PMID: 25972333 DOI: 10.1309/AJCP9EWI6QPVTPQY] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
150 Bidell MR, Pai MAP, Lodise TP. Use of Oral Tetracyclines in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia: A Literature Review on the Often-Overlooked Antibiotic Class. Antibiotics (Basel) 2020;9:E905. [PMID: 33327437 DOI: 10.3390/antibiotics9120905] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
151 Alammari KM, Thabit AK. Characteristics of patients infected with Clostridioides difficile at a Saudi Tertiary Academic Medical Center and assessment of antibiotic duration. Gut Pathog 2021;13:10. [PMID: 33593421 DOI: 10.1186/s13099-021-00405-9] [Reference Citation Analysis]
152 Gharbi M, Drysdale JH, Lishman H, Goudie R, Molokhia M, Johnson AP, Holmes AH, Aylin P. Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study. BMJ 2019;364:l525. [PMID: 30814048 DOI: 10.1136/bmj.l525] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 17.0] [Reference Citation Analysis]
153 Cohen ME, Hathway JM, Salmasian H, Liu J, Terry M, Abrams JA, Freedberg DE. Prophylaxis for Stress Ulcers With Proton Pump Inhibitors Is Not Associated With Increased Risk of Bloodstream Infections in the Intensive Care Unit. Clin Gastroenterol Hepatol. 2017;15:1030-1036.e1. [PMID: 28110095 DOI: 10.1016/j.cgh.2016.12.035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
154 Song YJ, Kim M, Huh S, Lee J, Lee E, Song KH, Kim ES, Kim HB. Impact of an Antimicrobial Stewardship Program on Unnecessary Double Anaerobic Coverage Prescription. Infect Chemother 2015;47:111-6. [PMID: 26157589 DOI: 10.3947/ic.2015.47.2.111] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
155 Knight BD, Shurgold J, Smith G, MacFadden DR, Schwartz KL, Daneman N, Gravel Tropper D, Brooks J. The impact of COVID-19 on community antibiotic use in Canada: an ecological study. Clin Microbiol Infect 2021:S1198-743X(21)00614-5. [PMID: 34757115 DOI: 10.1016/j.cmi.2021.10.013] [Reference Citation Analysis]